| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 141.424 | 142.885 | 160.963 | 192.825 | 195.820 | 191.743 | 199.773 | 250.549 | 111.079 | 97.416 |
| Total Income - EUR | 141.424 | 142.885 | 160.963 | 192.826 | 195.820 | 191.743 | 199.773 | 250.550 | 111.079 | 97.416 |
| Total Expenses - EUR | 132.679 | 136.680 | 155.820 | 181.788 | 182.723 | 179.692 | 185.313 | 232.414 | 103.812 | 90.268 |
| Gross Profit/Loss - EUR | 8.745 | 6.205 | 5.143 | 11.038 | 13.097 | 12.052 | 14.460 | 18.136 | 7.267 | 7.149 |
| Net Profit/Loss - EUR | 7.333 | 5.107 | 3.596 | 9.109 | 11.139 | 10.272 | 12.668 | 15.538 | 7.267 | 6.142 |
| Employees | 19 | 17 | 19 | 19 | 19 | 17 | 16 | 17 | 10 | 7 |
Check the financial reports for the company - Third Injection Unit Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 39.810 | 45.164 | 35.454 | 29.325 | 35.578 | 46.608 | 62.609 | 92.290 | 74.732 | 81.224 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 39.722 | 45.125 | 33.393 | 29.089 | 35.570 | 46.576 | 61.634 | 92.281 | 74.587 | 81.138 |
| Cash | 88 | 39 | 2.061 | 236 | 7 | 31 | 974 | 8 | 145 | 86 |
| Shareholders Funds | 12.176 | 17.159 | 20.320 | 9.324 | 20.284 | 30.172 | 42.171 | 57.841 | 64.932 | 70.712 |
| Social Capital | 225 | 223 | 219 | 215 | 213 | 209 | 204 | 205 | 204 | 203 |
| Debts | 27.634 | 28.005 | 15.133 | 20.001 | 15.293 | 16.435 | 20.437 | 23.430 | 9.088 | 9.804 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2651 - 2651" | |||||||||
| CAEN Financial Year |
2651
|
|||||||||
Comments - Third Injection Unit Srl